<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="that modulates host response by producing increased levels of cyclic" exact="adenosine" post="monophosphate (cAMP) and causing severe edema in infected host"/>
 <result pre="available for prevention or treatment of human disease, and while" exact="ribavirin" post="is sometimes used to treat Lassa fever, it is"/>
 <result pre="Screening of a small molecule library in this assay identified" exact="rifabutin" post="and ethavarine, as potential inhibitors of B. pseudomallei (Bp82)"/>
 <result pre="not reported, but likely high due to structure similarity to" exact="toremifene" post="Estrogen receptor modulator, human-free drug exposure = Ebola EC50"/>
 <result pre="triphosphorylated to the active drug. In humans, plasma concentrations of" exact="ribavirin" post="have been correlated to virological response Nucleoside drug; FDA"/>
 <result pre="to mice up to 250 mg/kg Nucleoside monophosphate prodrug of" exact="zidovudine" post="(AZT) [116] LASV, JUNV LHF-535 Entry inhibitor In vitro—yield"/>
 <result pre="Clindamycin Treatment of rabbits with systemic anthrax with clindamycin and" exact="ciprofloxacin" post="had improved efficacy compared to monotherapy and could be"/>
 <result pre="therapy for anthrax, including antiprotective antigen (PA IgG) antibodies and" exact="ciprofloxacin" post="in a rodent anthrax model increased survival significantly compared"/>
 <result pre="in a rodent anthrax model increased survival significantly compared to" exact="ciprofloxacin" post="treatment alone [157] Levofloxacin Raxibacumab Combination therapy with raxibacumab,"/>
 <result pre="IgG1 monoclonal antibody that binds protective antigen, and the antibiotic" exact="levofloxacin" post="provides protection in rabbits late in the disease course"/>
 <result pre="meropenem, or rifampin Linezolid Treatment of antibiotic-resistant inhalation anthrax with" exact="linezolid" post="and penicillin, meropenem, or rifampin had the inhibitory effect"/>
 <result pre="combination therapies used to treat pulmonary brucellosis in humans is" exact="doxycycline" post="and rifampin for 6 weeks [162] Burkholderia mallei Antibiotic"/>
 <result pre="antibiotic therapy to inhibit bacterial growth [163] Enrofloxacin, trimethoprim, and" exact="sulfadiazine" post="Doxycycline Successful 12-week combination treatment of parenteral administration of"/>
 <result pre="Successful 12-week combination treatment of parenteral administration of enrofloxacin and" exact="trimethoprim" post="with sulfadiazine followed by oral administration of doxycycline eliminated"/>
 <result pre="combination treatment of parenteral administration of enrofloxacin and trimethoprim with" exact="sulfadiazine" post="followed by oral administration of doxycycline eliminated B. mallei"/>
 <result pre="enrofloxacin and trimethoprim with sulfadiazine followed by oral administration of" exact="doxycycline" post="eliminated B. mallei from glanderous horses during an outbreak"/>
 <result pre="in vitro [165], [166] Ceftazidime Avibactam Avibactam restores susceptibility to" exact="ceftazidime" post="for genetically diverse extremely drug resistant isolates of Burkholderia"/>
 <result pre="isolates [166] Ceftazidime IFN-γ Interferon gamma–induced reactive oxygen species with" exact="ceftazidime" post="leads to synergistic killing of intracellular B. pseudomallei and"/>
 <result pre="equine antitoxin [169] Coxiella burnetii Doxycycline Chloroquine Combination therapy of" exact="doxycycline" post="and hydroxychloroquine combination shortened the duration of therapy and"/>
 <result pre="[169] Coxiella burnetii Doxycycline Chloroquine Combination therapy of doxycycline and" exact="hydroxychloroquine" post="combination shortened the duration of therapy and reduced the"/>
 <result pre="prosthetic aortic valve and aortic homograft was successfully treated with" exact="doxycycline" post="and chloroquine combination therapy [170], [171] Francisella tularensis Antibiotics"/>
 <result pre="valve and aortic homograft was successfully treated with doxycycline and" exact="chloroquine" post="combination therapy [170], [171] Francisella tularensis Antibiotics Uptake inhibitors"/>
 <result pre="Ciprofloxacin L-97-1 A novel postexposure medical countermeasure l-97-1, an A1" exact="adenosine" post="receptor antagonist blocks LPS-induced activation of immunomodulatory cytotoxic substance"/>
 <result pre="accumulation to prevent acute lung injury, and in combination with" exact="ciprofloxacin" post="improves survival of rats following infection with Y. pestis"/>
 <result pre="with poly(I:C), challenged with F. tularensis, and then treated with" exact="levofloxacin" post="showed 100% survival relative to no survival in animals"/>
 <result pre="showed 100% survival relative to no survival in animals receiving" exact="levofloxacin" post="alone [204]. Figure 7.5 Potentiating immune response by activating"/>
 <result pre="the potential to be repurposed as antiinfectives. Trifluoperazine (an antipsychotic)," exact="amoxapine" post="(an antidepressant), and doxapram (a breathing stimulant) mitigated fatal"/>
 <result pre="repurposed as antiinfectives. Trifluoperazine (an antipsychotic), amoxapine (an antidepressant), and" exact="doxapram" post="(a breathing stimulant) mitigated fatal Y. pestis infection in"/>
 <result pre="bubonic or pneumonic plague agents when administered in combination with" exact="levofloxacin" post="[208]. Multiple FDA-approved drugs targeting G-protein coupled receptors and"/>
 <result pre="the case of biothreat bacteria, the combination of Ceftolozone and" exact="tazobactam" post="exhibited increased in vitro susceptibility to a variety of"/>
 <result pre="Nipah virusMicrobes Infect212019 27GonzalezJ.P.EmonetS.de LamballerieX.CharrelR.ArenavirusesCurr Top Microbiol Immunol315200725328817848068 28RaabeV.N.KannG.RibnerB.S.MoralesA.VarkeyJ.B.MehtaA.K.Favipiravir and" exact="ribavirin" post="treatment of epidemiologically linked cases of Lassa feverClin Infect"/>
 <result pre="life into West Nile virus therapeutics; discovery and study of" exact="zafirlukast" post="as an NS2B-NS3 protease inhibitorEur J Med Chem15720181202121330193218 70QinQ.M.PeiJ.AnconaV.ShawB.D.FichtT.A.de"/>
 <result pre="pathogenesis and treatment with ribavirinJ Infect Dis141519805805896768812 114MorelloJ.Rodriguez-NovoaS.Jimenez-NacherI.SorianoV.Usefulness of monitoring" exact="ribavirin" post="plasma concentrations to improve treatment response in patients with"/>
 <result pre="rabbitsAntimicrob Agents Chemother591220157497750326392505 157KarginovV.A.RobinsonT.M.RiemenschneiderJ.GoldingB.KennedyM.ShiloachJ.Treatment of anthrax infection with combination of" exact="ciprofloxacin" post="and antibodies to protective antigen of Bacillus anthracisFEMS Immunol"/>
 <result pre="antigen of Bacillus anthracisFEMS Immunol Med Microbiol4012004717414734189 158MigoneT.S.BolmerS.ZhongJ.CoreyA.VasconcelosD.BuccellatoM.Added benefit of" exact="raxibacumab" post="to antibiotic treatment of inhalational anthraxAntimicrob Agents Chemother59220151145115125487792 159FossM.H.WeibelD.B.Oligochlorophens"/>
 <result pre="an extremely drug resistant (XDR) pathogen: avibactam restores susceptibility to" exact="ceftazidime" post="for burkholderia cepacia complex isolates from cystic fibrosis patientsACS"/>
 <result pre="Infect Dis37201750251128264560 167MosovskyK.SilvaE.TroyerR.Propst-GrahamK.DowS.Interaction of Interferon gamma-induced reactive oxygen species with" exact="ceftazidime" post="leads to synergistic killing of intracellular Burkholderia pseudomalleiAntimicrob Agents"/>
 <result pre="DupontH.RissJ.M.Arditi-DjianeJ.BrouquiP.Treatment of Q fever endocarditis: comparison of 2 regimens containing" exact="doxycycline" post="and ofloxacin or hydroxychloroquineArch Intern Med159219991671739927100 171CalzaL.AttardL.ManfrediR.ChiodoF.Doxycycline and chloroquine"/>
 <result pre="Q fever endocarditis: comparison of 2 regimens containing doxycycline and" exact="ofloxacin" post="or hydroxychloroquineArch Intern Med159219991671739927100 171CalzaL.AttardL.ManfrediR.ChiodoF.Doxycycline and chloroquine as treatment"/>
 <result pre="containing doxycycline and ofloxacin or hydroxychloroquineArch Intern Med159219991671739927100 171CalzaL.AttardL.ManfrediR.ChiodoF.Doxycycline and" exact="chloroquine" post="as treatment for chronic Q fever endocarditisJ Infect452200212712912217721 172D’EliaR.JennerD.C.LawsT.R.StokesM.G.JacksonM.C.Essex-LoprestiA.E.Inhibition"/>
 <result pre="resistance in Brucella melitensisInt J Antimicrob Agents3412009768119261448 185ValdezateS.NavarroA.Medina-PascualM.J.CarrascoG.Saez-NietoJ.A.Molecular screening for" exact="rifampicin" post="and fluoroquinolone resistance in a clinical population of Brucella"/>
 <result pre="187WebbJ.R.PriceE.P.CurrieB.J.SarovichD.S.Loss of methyltransferase function and increased efflux activity leads to" exact="doxycycline" post="resistance in Burkholderia pseudomalleiAntimicrob Agents Chemother6162017 188ChirakulS.NorrisM.H.PagdepanichkitS.SomprasongN.RandallL.B.ShirleyJ.F.Transcriptional and post-transcriptional"/>
 <result pre="Rep8120181065230006637 189SarovichD.S.WebbJ.R.PitmanM.C.VibergL.T.MayoM.BairdR.W.Raising the stakes: loss of efflux pump regulation decreases" exact="meropenem" post="susceptibility in Burkholderia pseudomalleiClin Infect Dis672201824325029394337 190SarovichD.S.PriceE.P.Von SchulzeA.T.CookJ.M.MayoM.WatsonL.M.Characterization of"/>
 <result pre="meropenem susceptibility in Burkholderia pseudomalleiClin Infect Dis672201824325029394337 190SarovichD.S.PriceE.P.Von SchulzeA.T.CookJ.M.MayoM.WatsonL.M.Characterization of" exact="ceftazidime" post="resistance mechanisms in clinical isolates of Burkholderia pseudomallei from"/>
 <result pre="isolates of Burkholderia pseudomallei from AustraliaPLoS One722012e3078922363490 191ChantratitaN.RhollD.A.SimB.WuthiekanunV.LimmathurotsakulD.AmornchaiP.Antimicrobial resistance to" exact="ceftazidime" post="involving loss of penicillin-binding protein 3 in Burkholderia pseudomalleiProc"/>
 <result pre="A108412011171651717021969582 192CummingsJ.E.SlaydenR.A.Transient in vivo resistance mechanisms of Burkholderia pseudomallei to" exact="ceftazidime" post="and molecular markers for monitoring treatment responsePLoS Negl Trop"/>
 <result pre="Antimicrob Chemother492200237938211815583 197VranakisI.De BockP.J.PapadiotiA.TselentisY.GevaertK.TsiotisG.Quantitative proteome profiling of C. burnetii under" exact="tetracycline" post="stress conditionsPLoS One732012e3359922438959 198LoVulloE.D.SherrillL.A.PerezL.L.PavelkaM.S.Jr.Genetic tools for highly pathogenic Francisella"/>
 <result pre="host-directed therapy against infectious diseasesNat Rev Immunol192201910411730487528 211NapierR.J.NorrisB.A.SwimmA.GiverC.R.HarrisW.A.LavalJ.Low doses of" exact="imatinib" post="induce myelopoiesis and enhance host anti-microbial immunityPLoS Pathog1132015e100477025822986 212ShiY.HeX.ZhuG.TuH.LiuZ.LiW.Coxsackievirus"/>
</results>
